Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

KemPharm KP415 Phase 1 Results and KOL Conference Call

Dec 14, 2016 from 4:30 PM to 4:30 PM EST